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Abstract 
Current research in the effectiveness of different aerobic exercise modalities for 
individuals with MS is incomplete. The primary aim of this study is to compare the 
aerobic response of six selected pieces of accessible exercise equipment at a moderate 
intensity, as indicated by the current exercise guidelines for individuals with MS. 
Exercise equipment preference was evaluated using a questionnaire. Participants (n=10) 
performed a steady-state exercise test on an arm ergometer, arm-leg recumbent stepper, 
body weight supported treadmill, arm-leg functional electrical stimulation (FES) 
recumbent stepper, arm FES cycle ergometer, and leg FES cycle. The average VO2 
(mlkgmin-1) was recorded on each piece of equipment. Here, the body weight support 
treadmill, arm leg FES recumbent stepper, and the arm leg stepper were significantly 
more aerobically demanding than the arm ergometer (p<.05). Further, there were no 
differences in pain (p> .05), safety (p> .05), enjoyment (p >.05), or anticipated 
adherence to exercise guidelines in duration (p >.05) or frequency (p> .05). In this study, 
all forms of accessible aerobic exercise were equally aerobically demanding and 
preferred in individuals with MS, with the exception of the arm ergometer being less 
aerobically demanding.  
 
 
 
 
 
 
 I 
Table of Contents 
Abstract	.......................................................................................................................................	II	
List	of	Tables	and	Figures	...................................................................................................	IV	
Abbreviations	...........................................................................................................................	V	
Acknowledgements	...............................................................................................................	VI	
Chapter	1:	Introduction	.........................................................................................................	1	
1.1	Rationale	........................................................................................................................................	1	
1.2	Objectives	and	hypothesis	.......................................................................................................	3	
Chapter	2:	Review	of	Literature	.........................................................................................	6	
2.1	Overview	of	multiple	sclerosis	as	a	disease	.......................................................................	6	2.1.1	Epidemiology	of	multiple	sclerosis	................................................................................................	6	2.1.2	Etiology	of	multiple	sclerosis	............................................................................................................	7	2.1.3	Clinical	course	of	multiple	sclerosis	...............................................................................................	8	2.1.4	Treatments	and	therapies	...............................................................................................................	10	
2.2	Exercise	and	multiple	sclerosis	...........................................................................................	12	2.2.1	Aerobic	fitness	......................................................................................................................................	12	
2.3	Exercise	preference	and	adherence	..................................................................................	23	
Chapter	3:	Methods	..............................................................................................................	25	
3.1	Participants	................................................................................................................................	25	3.1.1	Inclusion	criteria	.................................................................................................................................	25	
3.2	Procedures	.................................................................................................................................	26	3.2.1	Orientation	.............................................................................................................................................	26	
 II 
3.2.2	Familiarization	testing	......................................................................................................................	27	3.2.3	Aerobic	demands	of	each	exercise	...............................................................................................	28	3.2.4	Exercise	protocol	for	each	piece	of	equipment	......................................................................	31	
3.3	Outcome	measures	..................................................................................................................	34	
3.4	Statistical	Analysis	...................................................................................................................	36	3.4.1	Steady-state	submaximal	VO2	........................................................................................................	36	3.4.2	VO2	peak	..................................................................................................................................................	36	3.4.3	FES	vs.	Non-FES	...................................................................................................................................	37	3.4.3	Exercise	preference	............................................................................................................................	37	
Chapter 4: Results	..................................................................................................................	38	
4.1	Exercise	testing	adherence	...................................................................................................	38	
4.2	Submaximal	testing	measures	.............................................................................................	38	
4.3	VO2	peak	testing	measures	.......................................................................................................	39	
4.4	Comparing	non-FES	to	FES	exercise	...................................................................................	39	
4.5	Measures	of	exercise	preference	........................................................................................	40	
Chapter	5:	Discussion	..........................................................................................................	41	
5.1	Comparisons	of	aerobic	demand	during	moderate	exercise	....................................	42	
5.2	Comparisons	of	aerobic	demand	during	maximal	exercise	......................................	44	
5.3	FES	and	aerobic	exercise	.......................................................................................................	46	
5.4	Limiting	factors	of	FES	............................................................................................................	47	
5.5	Applicability	to	exercise	guidelines	...................................................................................	48	
5.6	Limitations	and	future	directions	......................................................................................	49	
Figures	and	Tables	...............................................................................................................	51	
References	..............................................................................................................................	56	
 III 
Appendix	A	..............................................................................................................................	63	
Appendix	B	..............................................................................................................................	65	
Appendix	C	..............................................................................................................................	66	
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 IV 
List of Tables and Figures 
 
Table 1  Participant characteristics  
Table 2  Comparisons between the FES vs. non-FES equipment for 
submaximal aerobic demand 
Table 3 One- way repeated measures ANOVA comparing preference of 
each piece of exercise equipment  
Table 4 Mean RPE scores on each piece of exercise equipment during 
submaximal exercise   
Figure 1 a comparison of the submaximal aerobic demands of each piece 
of exercise equipment  
 
 
 
 
 
 
 
 
 
 
 
 
 
 V 
Abbreviations  
CSEP Canadian society of exercise physiology 
ADL Activities of daily living 
BWSTT Body Weight Supported Treadmill Training 
CNS Central nervous system 
EDSS  Expanded Disability Status Scale  
EPQ Exercise Preference Questionnaire  
FES Functional electrical stimulation  
FES-A Functional electrical stimulation arm cycling 
FES-L Functional electrical stimulation leg cycling  
FES-LA Functional electrical stimulation arm and leg ergometer  
HR Heart rate 
HR max  Maximum heart rate  
MS  Multiple sclerosis  
RPE Rate of perceived exertion 
RRMS Relapsing-remitting multiple sclerosis 
PPMS Primary progressive multiple sclerosis  
SPMS Secondary progressive multiple sclerosis 
SCI  Spinal cord injury 
VO2 max Maximum volume of oxygen in liters per kilogram body weight 
VO2  Relative Volume of oxygen in liters per kilogram body weight  
VO2 peak Peak volume of oxygen in liters per kilogram body weight 
 
 VI 
Acknowledgements 
First, I would like to show my sincere appreciation to Dr. David Ditor for his 
continued support and mentorship throughout my academic career. Thank you for sharing 
your knowledge and expertise with me, as well as providing continuous opportunities at 
the Power Cord Center. Your passion for multiple sclerosis and spinal cord injury 
research, as well as your passion for teaching has enriched my experience as a graduate 
student. It is your genuine support that has made my achievement of completing a 
master’s degree possible. Additionally, I would like to thank the members of my 
committee: Dr. Phillip Sullivan, Dr. Stephen Cheung, and Dr. Deborah O’Leary for 
broadening my understanding of the research process, and providing me with feedback 
that has helped develop my skills as a researcher. I would also like to thank Dr. Audrey 
Hicks for her assistance as an external examiner.  Thank you to the graduate student 
team: Dr. David Allison, Dr. Hisham Sharif, Scott Donia, John White and Aastha Shah 
for their teamwork, friendship, and motivation. I cannot imagine working with a better 
team of individuals, thank you for always being reliable, and making the achievement of 
a masters degree such a positive experience. Lastly, I would like to thank all of the 
participants and Power Cord volunteers involved in this study for your constant 
optimism, and your patience with the extensive testing hours required for this study, I 
truly appreciate it.   
 1 
 
 
Chapter 1: Introduction  
1.1 Rationale  
Multiple Sclerosis (MS) is a neurodegenerative disease of the nervous system that 
affects motor, autonomic and cognitive functioning in afflicted persons. Global incidence 
rates of MS are on the rise, particularly in women (Rosati, 2001). In some parts of 
Canada (Barrhaven, Alberta) prevalence counts have been observed to be as high as 
196/100000 (Armstrong, Warren, & Warren, 1991). The natural course of the disease 
follows a gradual progression of disability, with a 15-year median time for reaching an 
expanded disability status scale (EDSS) score of 6, indicating those that have the ability 
to walk with a cane for not more than 100 meters without resting (see appendix A) 
following onset of the disease (Kremenchutzky, 2006).   
Most recently, exercise has been considered a therapeutic requirement for 
individuals with MS, as some disease symptoms are likely due to a combination of the 
disease course and living a sedentary lifestyle. Impairments due to an inactive lifestyle 
may be reversible with exercise. Additionally, exercise-induced anti-inflammatory effects 
may have potential in slowing the progression of the disease (Dalgas et al., 2008). 
Therefore, aerobic and resistance exercise training regimes have been implemented for 
this population. Among the many complications of MS, both peak (VO2 peak ) and 
submaximal aerobic capacities are significantly impaired  (Ponichtera-Mulcare, 1993). 
Oxygen consumption and aerobic endurance is reportedly lower among individuals with 
MS than predicted based on EDSS scores, further highlighting the importance of aerobic 
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training in this population (Kuspinar et al., 2010).   
In order to evoke cardiovascular improvements, individuals with MS are 
recommended to exercise at a moderate intensity of 55-60% of VO2 max (Dalgas et al., 
2008). However, considering the full and/or partial paralysis caused by this disease, 
reaching this intensity may prove difficult.  It has not yet been determined which piece of 
exercise equipment is ideal for aerobic training in individuals with MS in terms of 
exercise intensity and aerobic demands.  An ideal piece of aerobic exercise equipment 
would allow these individuals to exercise at moderate to high intensities in order to evoke 
physiological changes.   
There have been several attempts to identify appropriate exercise equipment to 
stimulate VO2 improvements. Arm ergometers have been used as a source of aerobic 
exercise, although findings have been inconsistent (Dalgas et al., 2008).  Additionally, the 
combined voluntary arm-leg exercise via the NuStep machine has been used for moderate 
to high intensity exercise (as rated by the Borg scale) for individuals with severe cases of 
MS. This exercise demonstrated a strong trend to increase VO2 peak, although the results 
were inconclusive due to the small sample size (Skerbaek, 2014). 
A pilot study by Giesser and collegues (2007) showed significant improvements 
in mobility following body-weight support treadmill training, although it was difficult to 
ascertain the level of aerobic demand that took place during this study. Likewise, 
functional electrical stimulation (FES) has been shown to improve walking speed and 
distance in individuals with MS (Barrett, Mann, Taylor, & Strike, 2009), although there is 
no evidence that FES exercise intensity is aerobic.  Therefore, current research involving 
specific aerobic exercise machines, particularly FES exercise, is incomplete. 
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1.2 Objectives and hypothesis  
Objective 1:  
The primary objective of this study was to determine which piece of exercise 
equipment (from a selection of six common pieces) evokes the greatest aerobic demand 
when used at moderate intensity. This study examined FES-arm exercise (FES-A), FES-
leg exercise (FES-L) and FES arm-leg exercise (FES-LA), voluntary arm crank 
ergometry, voluntary leg exercise (with body-weight supported treadmill training; 
BWSTT) and voluntary arm-leg exercise (with the NuStep machine). FES- arm exercise 
and FES-leg exercise was conducted on the RT300, and FES arm-leg exercise was 
conducted on the RT200 (Restorative therapies, Baltimore, MD) 
Objective 2:  
As a secondary objective, we aimed to determine which piece of exercise 
equipment required the greatest aerobic demand (VO2 peak) when used at a maximal 
intensity. For this objective, we evaluated the voluntary arm-leg exercise with the NuStep 
machine and the FES-arm-leg exercise with the RT200. These two pieces of equipment 
were chosen as anecdotally they appear to be the most aerobically demanding.  
Objective 3:  
 As a tertiary objective, we aimed to determine if the addition of FES for any of 
the given exercises (arm ergometry vs. FES- arm exercise, NuStep vs. FES-arm and leg 
exercise, BWSTT vs. FES- leg exercise) adds significant aerobic demand when 
exercising at a perceived moderate workload.  
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Objective 4:  
 As a fourth objective, we aimed to determine which piece of exercise equipment 
individuals with MS prefer when exercising at a moderate intensity.  
Hypothesis 1:  
We hypothesized that voluntary arm-leg exercise on the NuStep and arm-leg FES 
exercise on the RT 200 would be the most aerobically demanding exercises when 
performed at a moderate intensity. The recumbent arm-leg cycle using the NuStep and 
arm-leg FES exercise using the RT200 recruit more major muscle groups during the 
exercise compared to the other four listed exercises. Therefore, it is expected that they are 
more aerobically demanding. 
Hypothesis 2: 
Further, we hypothesized that the added benefit of electrical stimulation will 
allow for a greater VO2 peak on the RT200 when compared to the NuStep.  We 
hypothesized this because the FES capability of the FES-AL enables the participant to 
contract the muscle groups involved in the exercise beyond volitional capacity. This 
would therefore evoke a greater aerobic demand.  
Hypothesis 3: 
We hypothesized that addition of FES-stimulation to a given exercise movement would 
increase aerobic demand during submaximal exercise. By matching exercise equipment 
in terms of movement, the addition of FES should produce a higher aerobic response, 
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which is consistent with having the muscles involved in the exercise being recruited 
beyond volitional capacity.  
 
Hypothesis 4:   
Finally, we hypothesized that there would be no difference in preferred piece of 
exercise equipment based on pain, safety, enjoyment, and adherence to exercise 
guidelines. This hypothesis is consistent with results found in a study by Pelletier and 
colleagues (2014) on exercise preference in a population with spinal cord injury.  
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Chapter 2: Review of Literature  
2.1 Overview of multiple sclerosis as a disease 
MS is an immune-mediated disease characterized by chronic inflammation of the 
central nervous system (CNS). The progressive decline in nerve function is attributed to 
the destruction of myelin around neurons (Tullman, 2013). Myelin is a key component of 
white matter, as it protects the nerve and accelerates nerve conduction (Simons & Lyons, 
2013). This destruction of myelin occurs when immune cells such as pro-inflammatory 
Th cells, B cells, and macrophages target the myelin surrounding nerves, and produce 
pro-inflammatory cytokines, such as IL-2, IL-23, interferon γ, and tumor necrosis factor-
α.   These cytokines break down the myelin and myelin-producing cells called 
oligodendrocytes. Lesions are left in the areas damaged by immune cells and cytokines. 
Nerves in lesioned areas are susceptible to damage, which can impair or block nerve 
conduction. Although the structural damage is considered irreversible, improvements in 
nerve function are sometimes observed and attributed to decreases in inflammation, and 
the reorganization of sodium channels (Tullman, 2013).  Such recovery is never full, and 
the persistent neural deficits result in functional symptoms such as decreases in strength, 
coordination, and sensation (Rietberg et al., 2011).  
2.1.1 Epidemiology of multiple sclerosis  
 Canada has one of the highest incidence rates of MS worldwide, and this rate is 
increasing.  A review conducted by Rosati (2001) reported Saskatoon, Saskatchewan as 
having the world’s highest incidence rate, reaching 248 per 100 000 in the year 1999 
(Hader, 1999). Currently in Ontario, there are approximately 25,000 individuals living 
with MS, with a prevalence of 204 cases per 100,000 and rising, which is consistent with 
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other Canadian provinces. Incidence rates increase directionally from the western 
seaboard of Canada to the eastern seaboard. The higher density of immigrants of French 
decent on the eastern boarder is a possible explanation of this prevalence gradient 
(Rosati, 2001), as the highest prevalence of MS worldwide is among European, 
American, and Australian continents (Ascherio & Munger, 2007).  
2.1.2 Etiology of multiple sclerosis 
Currently, the cause of MS is unknown, however many risk factors have been 
identified (Tullman, 2013). Ethnicity is an important risk factor for the development of 
MS. Individuals that migrate from low risk countries (such as Asian decent countries) to 
high risk countries (such as Canada and the United Kingdom) are somewhat protected, 
and are less likely to develop MS. This protective effect is also transferable to the 
children of immigrants, however, these children are at greater risk of developing MS than 
their parents (Ascherio & Munger, 2007). This suggests alternative environmental risk 
factors independent of ethnicity. Latitude has been identified as a possible risk factor in 
the development of MS, as countries located further from the equator have reported 
higher prevalence rates. However, recently this latitude difference has been decreasing, as 
prevalence in southern regions has been increasing more rapidly than northern regions 
(Ascherio & Munger, 2007). 
 Historically, sex has played an important role as an MS risk factor. In Canada, 
there has been a consistent increase in female cases of MS over the last 50 years. From 
1931-1935, the mean female: male ratio was approximately 1.9, whereas in 1980, this 
ratio was estimated at close to 3.2. The cause of this large increase in the ratio is 
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unknown, however proposed factors include a change in the typical child bearing age, 
more women in the work force and a change in the age of menarche (Orton et al., 2006). 
2.1.3 Clinical course of multiple sclerosis  
MS is considered a long-term disease and the rate and severity of progression is 
dependent on its subtype. MS is categorized into progressive MS and relapsing MS.  
These are further divided into four subtypes: relapsing remitting MS (most common and 
least aggressive), secondary progressive MS, primary progressive MS, and progressive 
relapsing MS (most aggressive). These four categories are considered dynamic, as most 
individuals with relapsing remitting MS will progress to secondary progressive MS over 
time (Weiner & Stankiewicz, 2012).  
Upon initial diagnosis, relapsing remitting MS is the most common type and 
accounts for 80% of all initial diagnoses (Ebers, 2006). Relapsing remitting MS (RRMS) 
follows a recognizable and consistent pattern, where the onset is characterized by sudden 
neurological impairment, which is called a relapse. From the point of onset, the person 
will experience an individualized pattern of relapses that occur at steady intervals. Over 
time, the frequency of relapses declines by an average of 0.4 relapses per year (Ebers, 
2006), however, it is unknown how the frequency and severity of the relapses affects long 
term disability outcomes (Ebers, 2006). The decline in relapses contributes to disease 
transition from relapsing remitting MS to secondary progressive MS. This transition 
pattern is recognized in 80% of the MS population that is initially diagnosed with 
relapsing remitting MS (Ebers, 2006).  
Secondary progressive MS is first diagnosed as RRMS, and later through disease 
progression turns into secondary progressive MS. It is characterized by the absence of 
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regular relapses, with continued steady disability occurring overtime (Goodin et al., 
2002).  
Primary progressive MS is a rare form of the disease where disability 
progressively worsens. Furthermore, the lesions associated with this type of MS 
predominantly affect the spinal cord. This form of MS is difficult to diagnose and may 
differ both immunologically and pathologically from relapsing remitting MS, although it 
is generally more severe symptomatically over time (Thompson et al., 1997).  
Progressive relapsing MS is a form of the disease where progression overtime 
occurs in the form of both acute attacks and steady disability. Patients with progressive 
relapsing MS therefore experience relapses, however disability is not only attributed to 
these relapses (Goodin et al., 2002). 
Declines in function are clinically assessed using the expanded disability status 
scale (EDSS). The EDSS is the successor to the original disability status scale, which was 
revised in order to detect smaller changes in function in the mid range of the scale.  The 
EDSS rates disability on a scale of 0 (normal function) to 10 (death due to MS). 
However, the increments in which the scale increases are not constant, as half grades 
were incorporated as part of the revision (See appendix A) (Kurtzke, 1983). The EDSS 
can mark specific functional ability milestones. For example, an EDSS of 7 corresponds 
to an individual being confined to a wheelchair. The progression of MS can therefore be 
followed using the EDSS (Ebers, 2006).  
The average life expectancy in individuals with MS is 5-7 years less than the 
general population (Ebers, 2006). MS generally progresses slowly over the course of 30-
40 years. During this time, disability accumulates and becomes irreversible. For example, 
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the average time to developing an EDSS of 6 in relapsing remitting MS is 15 years 
(Ebers, 2006). Furthermore, approximately 50% of individuals with MS will require 
some form of ambulation aid within 10 years of diagnosis (Giesser et al., 2007). 
Therefore, medications and treatments are explored in order to prolong an individual’s 
ambulatory lifestyle following diagnosis of MS.  
In addition to physical disability, cognitive impairment is also common in 
individuals with MS. The prevalence of cognitive impairment ranges from 43% to 70%, 
with prevalence higher in later stages of the disease. The most common symptoms of 
cognitive impairment in individuals with MS are diminished long term memory, 
processing speed, and visual learning (Chiaravalloti & DeLuca, 2008).  
2.1.4 Treatments and therapies  
2.1.4.1 Pharmacological treatments  
 There is currently no cure for MS. However, treatments are available that aim to 
shorten the length of exacerbations, decrease the number of exacerbations, and provide 
relief of symptoms relating to relapses. A common drug therapy used in the treatment of 
acute relapses is a corticosteroid called prednisone (Goldenberg, 2012). The use of 
corticosteroids has been shown to decrease the length of time a relapse lasts, however it is 
not effective in preventing further disability. Therefore, all drug treatments recommended 
for individuals with MS are merely for symptom management.  The usual course of 
corticosteroid treatment is a three-day intravenous protocol (Murray, 2006).  
 Beta-interferon is another form of drug therapy recommended for individuals with 
MS. This drug is predominantly recommended for individuals with RRMS as it has 
shown to reduce the incidence of relapse by 30%. These drugs are naturally occurring 
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cytokines with anti-inflammatory properties, and they have been shown to decrease the 
inflammation in MS lesions. However, this drug can have severe adverse side effects 
such as thyroid disease, decreased liver function, and leukopenia. Furthermore, it is still 
not associated with slowing disability progression (Goldenberg, 2012). Non-
pharmacological options have been explored for people with MS given this limited 
efficacy for drug therapies.  
2.1.4.2 Non-pharmacological therapies  
 Exercise rehabilitation may be an important treatment for MS, considering drug 
therapies have not been proven effective in the prevention of disease progression.  A 
systematic review conducted by Sá  (2014), examined randomized control trials regarding 
exercise and MS between the years 2004 to 2012. This review concluded that there are 
potential benefits in the prescription of rehabilitative exercise for those with MS. 
Additionally, a Cochrane systematic review was performed by Rietberg et al. (2011), 
which examined the effects of exercise on health related quality of life and activities of 
daily living in individuals with MS. This review was the first to isolate the effects of 
exercise therapy on these two variables, and it concluded that there was strong evidence 
supporting exercise as an effective treatment in regards to increasing muscle power and 
mobility activities for individuals with MS.  
 Furthermore, exercise is commonly used as a therapy for treating comorbidities of 
MS. Marrie and colleagues (2008) examined the prevalence of comorbidities in 
individuals with MS. It was found that hypercholesterolemia and hypertension were the 
most common comorbidities in this population. It is well known that a sedentary lifestyle 
is a risk factor for developing cardiovascular disease (Myers et al. 2007). Individuals with 
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MS are particularly susceptible to leading a sedentary lifestyle and therefore, integrating 
exercise into the lives of individuals with MS is also important for the  prevention of 
morbidities common in sedentary individuals (Latimer- Cheung et al., 2013). 
2.2 Exercise and multiple sclerosis 
2.2.1 Aerobic fitness  
Traditionally, exercise was not prescribed for individuals with MS as physicians 
seemed to agree that exercise would enhance acute fatigue symptoms. However, two 
studies conducted in the late 1990s (Petajan et al., 1996; Ponichtera-Mulcare et al., 1997) 
provided evidence to the contrary.  
Ponichtera-Mulcare and colleagues (1997) explored the effects of exercise in two 
groups of individuals with MS. One group was ambulatory (EDSS 1.0-4.5) and the other 
was semi-ambulatory (EDSS 5.0-6.0). Both groups underwent a six-month training 
program, consisting of leg cycling ergometry three times per week for 30 minutes per day 
at 65-70% of maximum heart rate (as calculated by 220-age). This study showed that it is 
safe for individuals with MS to exercise at a moderate intensity, and to perform VO2 max 
testing. Further, a trend for improved aerobic capacity of 19% in the ambulatory group 
and 7% in the semi-ambulatory group was found at the conclusion of the 24-week 
training study.   
Petajan et al. (1996), used an exercise group and a non-exercise control group in 
individuals with MS. Both groups had a maximum disability EDSS score of six. 
Participants in the exercise group trained 40 minutes three times per week for 15 weeks 
using a cycle ergometer at 60% of VO2 max.  A significant increase (pre: 24.2 l/min, post: 
29.4 l/min, p<.05) in VO2 max was found in the exercise group compared to no change 
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(pre: 26.0 l/min, post: 26.4 l/min, p<.05) in the non-exercise control group. Furthermore, 
improvements in ambulation mobility, body care, and movement scores were noted. The 
evidence from these two studies suggests that cardiovascular exercise is potentially 
beneficial for individuals with MS. Furthermore, the improvements in aerobic capacity 
are similar to a non-MS control population (Petajan et al., 1996,  Ponichtera-Mulcare et 
al., 1997).  
Evidence regarding the benefits of aerobic fitness in the general population is well 
known. Some of these benefits include a decrease in the risk of cardiovascular disease, 
type II diabetes, osteoporosis, and depression (Mostert & Kesselring, 2002). These 
benefits of aerobic fitness have also been demonstrated in multiple special populations 
(Mostert & Kesselring, 2002). Therefore, it is now generally accepted that aerobic 
exercise will have the same beneficial effects on an MS population (Mostert & 
Kesselring, 2002). 
 In addition to these health benefits, aerobic exercise may be able to counteract 
symptoms unique to MS. Schmidt and Wonneberger (2014), studied the long-term effects 
of aerobic exercise on VO2 peak and fatigue (as indicated by the fatigue severity scale 
score (FSS). The participants were ambulatory and diagnosed with relapsing remitting 
MS. Each participant followed an individualized aerobic training program for 12 months.  
A subgroup analysis was performed in order to identify changes in VO2 peak when fatigue 
was present (as indicated by an FSS>4), as well as when fatigue was absent (FSS< 4).  
The findings showed improvements in VO2 peak in both groups, however improvements in 
VO2 peak when fatigue is absent plateaued at six months of training. In the subgroup where 
fatigue was present, there were improvements in VO2 peak throughout the 12-month 
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training period. Further, there was a small but statistically significant decrease in fatigue 
levels following  nine months of this exercise program (p<0.03). These findings 
demonstrate that aerobic exercise may be important in controlling fatigue symptoms in a 
population with relapsing remitting MS (Schmidt & Wonneberger, 2014).  
In addition to the benefits it confers to MS symptoms, recent literature has 
reviewed the effects of exercise in preventing disease progression (Dalgas & Stenager, 
2012). Although current clinical outcome measures of MS are not sensitive enough to 
provide definite conclusions, a recent review shows some evidence supporting exercise as 
an effective means of slowing disease progression (Dalgas & Stenager, 2012). For 
example, improvements in VO2 peak have been positively correlated to disease-specific 
variables, such as improvements in walking performance and cognitive speed 
(Langeskov-Christensen et al., 2014). Additionally, there is evidence suggesting that VO2 
max improvements may prevent structural damage to the brain which is a result of disease 
progression (Langeskov-Christensen et al., 2014).  
 Nevertheless, VO2 max has been found to be much lower in the MS population 
compared to the non-MS population (Kuspinar et al., Mayo, 2010; Langeskov-
Christensen et al., 2014). Evidence shows that individuals with MS have a VO2 peak which 
is in the 25th percentile compared to a healthy population (Kuspinar et al., 2010). An 
increase in EDSS score is an indicator of a decrease in VO2 max, suggesting a negative 
correlation between disability status and VO2 max in the MS population (Langeskov-
Christensen et al., 2014).  
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2.2.1.1 Reliability and validity of VO2 max in multiple sclerosis  
 
There is some debate as to whether VO2 max or VO2 peak is the appropriate 
terminology in the MS population. Recent research offers strong support that VO2 max is 
the more correct term when conducting maximal effort aerobic testing for individuals 
with MS.  
VO2 max is defined as the maximum oxygen the whole body consumes during 
maximal exercise. Primary and secondary criteria are used to identify when an individual 
reaches their VO2 max. The primary criterion for identifying VO2 max is a plateau in oxygen 
consumption, despite an increase in workload. However, it is common for a healthy 
individual to be unable to reach this point in exercise. Further, it is likely that persons 
with MS will be unable to achieve this workload. Therefore, secondary criteria have been 
created, and include achieving a respiratory exchange ratio (RER) greater than 1.15, 
achieving calculated maximum heart rate (HRmax), reaching 17 or higher on the Borg 
scale, and a high concentration of lactate in blood following exercise (Langeskov-
Christensen et al., 2014).  
Langeskov-Christensen and collegues (2014) tested the validity of these criteria, 
as well as the reliability of the VO2 max test specifically for individuals with MS. This 
study found that only 40% of persons with MS could achieve the primary criteria, 
whereas achievement of any of the secondary criteria measures ranged from 65-95%. 
Therefore, the secondary criteria may be more helpful when determining VO2 max in the 
MS population. Considering the low achievement of the primary criteria, VO2 max is often 
referred to as VO2 peak for this population (Langeskov-Christensen et al., 2014). 
Furthermore, particular secondary criteria have been found to be more valid than others 
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in persons with MS. The achievement of HRmax may not be an ideal criteria for VO2 max 
testing for those with MS, as previous work has shown only 65% of this population were 
able to achieve age-predicted max heart rate (HR) (Langeskov-Christensen et al., 2014). 
Further, medications (such as beta blockers), which are common in this population, may 
affect HRmax. Rate of perceived exertion (RPE) is a measure of exercise intensity where 
the participant uses a scale to identify how hard they are working. The attainment of  a 
RPE that was greater than 17 on the Borg’s 6-20 scale, as well as a respiratory exchange 
ratio greater than1.15 were found to be the best indicators of VO2 max, as 95% and 90% 
respectively of an MS sample were able to achieve this criteria.  
The test-retest reliability of VO2 max has also been studied in those with MS. VO2 
max was found to be a reliable measure of fitness, however to account for day-to-day 
differences in VO2 max,, a minimum change in VO2 max of 11% must be made to be 
considered a meaningful cardiovascular improvement (Langeskov-Christensen et al., 
2014). 
2.2.1.2 Aerobic exercise prescription for individuals with Multiple Sclerosis 
Currently, exercise is prescribed to individuals with MS but guidelines regarding 
dose, duration, and type are only recently emerging. The first exercise guideline review 
was created by Dalgas and collegues (2008). This review aimed to make endurance and 
resistance exercise training guidelines that were easily accessed and understandable for 
clinical use. For endurance exercise, the guideline suggests exercising 2-3 times per 
week, for 10-40 minutes at 50-70% of VO2 max. Further, it is suggested that progression 
should be in the form of increasing volume and frequency. The exercise modalities 
suggested in this review were divided based on ambulatory ability. For individuals who 
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are less ambulatory, arm-ergometry, leg-ergometry, arm-leg ergometry, and treadmill 
walking were suggested. For individuals who are more ambulatory, aquatic exercise, 
rowing, road biking, and running were suggested. However, a limitation noted in this 
guideline is that it is not known what modality is optimal for eliciting an aerobic 
response.  
Following this review, the American College of Sports Medicine (ACSM) 
developed evidence-based exercise guidelines for individuals with MS (Latimer-Cheung 
et al., 2013). This guideline is based on performing the minimum required exercise in 
order to achieve “important health benefits.” Similar to the Dalgas et al. (2008) guideline, 
recommendations are suggested for both endurance and resistance exercise. Further, these 
guidelines are applicable to individuals who have mild to moderate MS, as indicated on 
the EDSS of a score 0-8. The endurance component of these exercise guidelines suggests 
a minimum of 30 minutes of endurance exercise, at a moderate intensity no less than two 
times per week. A moderate intensity is indicated by a score of 6 on the 10-point RPE 
scale. Further, this guideline provides similar activity modality suggestions to that in the 
Dalgas et al. (2008) guidelines, but it remains unclear which modality is recommended 
for achieving optimal exercise for the MS population.  
2.2.1.5 Modalities of aerobic exercise  
 More research is needed on the aerobic demand of various modalities of aerobic 
exercise that can be used in the MS population. This information is necessary to further 
develop the current MS exercise guidelines (Latimer-Cheung et al., 2013). There are 
some aerobic exercise modalities that are common among other populations with 
neurological impairment. These modalities may be able to be transferred to the MS 
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population, however these pieces of equipment have not yet been examined.  
Furthermore, aerobic exercise involving functional electrical stimulation (FES) is 
common among persons with neurological impairment (Peng et al., 2011). Thus, the 
following exercise modalities have been identified for populations with neurological 
impairment.  
i) Traditional aerobic exercise modalities 
There are many types of exercise that provide an aerobic stimulus, however for 
the purpose of this review, rehabilitative exercise modalities, which can be used by a 
wide range of disability severities have been included. Three types of exercise that have 
been used in persons with MS are arm ergometry, recumbent arm-leg exercise (NuStep), 
treadmill training and body weight supported treadmill training (BWSTT). 
There is a paucity of research involving aerobic training on recumbent arm-leg 
exercises. In an aerobic exercise feasibility study by Skjerbæk et al. (2014), recumbent 
arm-leg was one type of exercise used when creating individualized exercise programs 
for individuals with severe MS. Participants were randomized in to a control or exercise 
group. The exercise group participated in ten exercise sessions as part of a four-week 
inpatient rehabilitation program involving endurance arm-leg exercise using the NuStep 
machine. Exercise sessions involved interval training at 65%-75% of VO2 peak. Results 
showed that there was a trend toward a group*time interaction for VO2 peak improvements 
in the exercise group (p=.06). However, as other forms of exercise training were also 
used in this study, the specific aerobic effects of recumbent arm-leg exercise are not 
known.  
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Treadmill training is a common form of exercise after a stroke, but is not yet well-
studied in persons with MS (Van den Berg et al., 2006). A pilot study by Van den berg 
and colleagues (2006) tested the effects of treadmill training on fatigability and walking 
performance in persons with MS. Participants exercised on a treadmill three times per 
week for four weeks. Training intensity was progressed by increasing exercise duration to 
a maximum of 30 minutes. Speed was also increased, with the goal of achieving 55-85% 
of HRmax. Following four weeks of training, there was a significant improvement in 
walking ability but no changes in fatigue. Aerobic demand was not measured in this 
study; therefore the aerobic demand of this exercise is unknown in this population. This 
suggests treadmill training is feasible for persons with MS and may be a good mode of 
aerobic exercise, however its effectiveness as an aerobic stimulus is not fully understood 
(Van den Berg et al., 2006).   
A study by Pilutti and collegues (2011) assessed the effect of BWSTT on 
functional ability, fatigue, and quality of life in people with primary progressive MS. 
Participants in this study trained for 30 minutes, three times per week for 12 weeks. 
Training was progressed by increasing the speed of the treadmill and subsequently 
decreasing body weight support. Following the exercise training protocol, results showed 
that following training participants remained stable in functional ability and improved in 
quality of life (QOL) outcome measures. However, there was no significant affect on 
fatigue. Progression of training intensity and improvements on QOL outcome measures 
may indicate that BWSTT is a suitable exercise for the MS population. However, there 
are currently no studies that examine the effects of BWSTT on aerobic capacity in the 
MS population.  
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Arm ergometry is a common exercise among populations with neurological 
impairment (Hicks et al., 2003; Mostert & Kesselring, 2002; Skjerbæk et al., 2014). 
Furthermore, the current exercise prescription guidelines for persons with MS suggests 
arm ergometry as an effective mode of aerobic exercise (Dalgas et al., 2008; Latimer-
Cheung et al., 2013). Whether or not this is the optimal mode of exercise for aerobic 
gains in individuals with MS is unknown, and it is important to compare its value against 
other forms of exercise. Some research has shown aerobic and functional benefits in the 
MS-population, however the actual aerobic demands of each exercise modality are 
unknown.  
ii) Functional electrical stimulation (FES) exercise 
FES is an emerging form of exercise for individuals with MS. Chang and 
collegues (2011), studied the feasibility of FES exercise, and its effects on muscular 
strength and fatigability in individuals with MS. Traditionally, it was felt that traditional 
voluntary exercise may be contraindicated for individuals with MS, because of the 
potential for the severe and debilitating fatigue that would result from challenging the 
central nervous system (CNS). Therefore, exercise that bypasses the CNS may be 
beneficial as a means of preventing this exercise-induced fatigue. FES exercise 
challenges the peripheral nervous system (PNS), while bypassing the CNS, and therefore 
it may be an ideal exercise modality for the MS population (Chang et al., 2011). In a 
study by Chang and colleagues (2011), individuals with MS in this study participated in 
an isometric knee extension FES training program. In this program, stimulation was 
applied to the quadriceps in order to facilitate knee extension. Participants exercised in a 
chair that held the knee fixed at a 90° angle in order to elicit isometric contractions using 
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FES. This training was performed at home three days per week for 30 minutes per day for 
eight weeks. Fatigue was measured using the Modified Fatigue Impact Scale (MFIS). 
Further, the generalized estimating equations model was then used to identify the 
contribution of both central and peripheral fatigue to general fatigue. The study by Chang 
and colleagues (2011) showed that FES exercise is in fact feasible in persons with mild to 
moderate MS (EDSS 1.0-4.0).  Furthermore, results showed that fatigue related to the 
CNS was rated higher than fatigue related to the PNS. Following this eight-week training 
program, there was an increase in fatigue resistance in the quadriceps, and this was 
attributed to improvement in fatigue resistance related to the CNS using general 
estimating equations. However, more research is necessary to determine the aerobic 
demands of FES exercise on persons with MS (Chang et al., 2011).  
 The cardiovascular effects of FES exercise have yet to be determined in persons 
with MS but have been widely studied in other populations with neurological impairment, 
such as spinal cord injury (SCI), cerebral palsy, and stroke. In individuals with SCI, there 
is evidence that FES exercise training can elicit enough of a cardiovascular response to 
increase VO2 peak, capillary density, cross sectional area of arteries, blood inflow volume, 
and cardiac output (Peng et al., 2011),  including a  20-35% increase in peak oxygen 
uptake following 12-26 weeks of FES-cycling exercise training. Furthermore, the oxygen 
demand associated with this exercise is equivalent to the oxygen demand of walking in 
the able-bodied (Peng et al., 2011). These aerobic benefits may also be realized in a MS 
population, and highlight the importance of including FES exercise training as a modality 
of exercise for persons with MS.  
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 There are many modes of FES exercise, such as FES arm cycling, leg cycling, and 
elliptical ergometry. FES leg cycling is commonly used, and FES arm-leg ergometry is an 
emerging piece of exercise equipment. Both pieces of equipment stimulate the legs using 
the quadriceps, hamstring, and gluteal muscles. However, the FES-elliptical trainer 
moves the legs through a seated-stride pattern, compared to the cyclic pattern of the FES 
leg cycle. A study by Hamzaid and collegues (2012) compared the aerobic effects of leg 
cycling exercise to leg elliptical exercise in individuals with SCI. The VO2 peak, VCO2 peak 
and VE were greater on the elliptical trainer than the leg cycle. Additionally, force 
generated using the elliptical trainer was twice that achieved on the cycle, suggesting 
possible strength training implications. Stimulation using both the arms and legs during 
elliptical FES exercise has not yet been examined. However, a new piece of technology 
developed by Restorative Therapies Innovations (Baltimore, MA) enables an individual 
to exercise while simultaneously stimulating the arms and legs. This equipment (RT200) 
has not yet been tested on persons with MS, however given the aerobic benefit seen in the 
SCI population it may be an ideal piece of exercise equipment to use for aerobic exercise 
in individuals with MS. No research to date has examined the aerobic demand of FES 
arm ergometry.  
2.2.1.4 RPE for individuals with MS  
 Exercise intensity in persons with MS is commonly estimated using an RPE scale. 
One common scale is the Borg 6-20 RPE (Borg, 1990). Use of an RPE scale has been 
shown to be a valid indicator of exercise intensity for both disabled and able-bodied 
populations (Morrison et al., 2008). Further, in a population with MS, using an RPE scale 
may be a better indicator of exertion compared to other common criteria (i.e. HR) 
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(Morrison et al., 2008). A study by Anema et al. (1991)  reported that in a sample of 
persons with MS, 53% had evidence of cardiovascular autonomic dysfunction, and 28% 
of these participants also had an abnormal HR response to standing. Therefore, HR may 
not be an accurate measure of exertion during exercise in this population. Currently, RPE 
has been included in the MS exercise guidelines for estimating intensity during endurance 
exercise (Latimer-Cheung et al., 2013), and it has been used in studies involving aerobic 
exercise for individuals with MS (White et al., 2000).  
2.3 Exercise preference and adherence  
A meta-analysis by McAuley and collegues (2007) showed that people with MS 
participate less in physical activity programs than able-bodied individuals. This may be 
particularly alarming considering exercise has been shown to effectively treat symptoms 
of MS (McAuley et al., 2007).  Therefore, it is important to identify what aerobic exercise 
is preferred amongst persons with MS in order to prevent withdrawing from an exercise 
program. Furthermore, self-efficacy has been associated with exercise adherence 
(McAuley et al., 2007), and thus identifying equipment this population enjoys and is 
confident using may affect exercise adherence. 
In able-bodied persons, preference to a type of exercise has been correlated to 
motivation and exercise adherence (Daley & Maynard, 2003). An exercise preference 
questionnaire was developed by Pelletier and collegues (2014) in order to determine what 
exercise equipment people with spinal cord injury preferred using. This questionnaire 
included four sections: pain, safety, enjoyment, and adherence to spinal cord injury 
exercise guidelines. Participants were asked to rate each piece of equipment used in the 
study with this questionnaire. The aerobic exercise equipment used included an arm 
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ergometer, arm glider, arm leg recumbent stepper, and arm leg cycle ergometry. The 
results from this study indicated that there were no differences in perceived enjoyment 
using the various types of aerobic exercise equipment. However, perceived safety was 
lower on the arm leg recumbent stepper compared to the other three pieces of exercise 
equipment. With this considered, they determined that promoting the use of arm only 
exercise for individuals with SCI may be ideal as it appeals to a broader spectrum of 
abilities for the same enjoyment.  
A study by Pilutti and colleagues (2016) assessed exercise preference on the arm 
and leg recumbent stepper, as well as the body weight support treadmill trainer 
(BWSTT). It was found that after 12-weeks of exercise, the arm and leg recumbent 
stepper was preferred among individuals with MS. This is currently one of the only 
studies examining exercise preference in individuals with MS. In order to improve 
exercise adherence in people with MS, it is important to identify what exercise equipment 
is preferred. 
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Chapter 3: Methods  
3.1 Participants 
Ten participants were included in the study. Ages ranged from 42-65 years of age. 
Participants were recruited from the Power Cord Exercise Program at Brock University, 
as well as the MS Society Niagara community. All participants recruited had some ability 
to walk, as indicated by an EDSS score of 7 or lower.   
3.1.1 Inclusion criteria 
 To be eligible for inclusion into this study, participants required a diagnosis of 
MS obtained at least one-year prior to enrollment, general medical stability, be between 
the ages of 18-75 years, and have a self-reported EDSS score between 3 and 7. The full 
EDSS scale can be found in Appendix A, however, in brief an EDSS score of 3 indicates 
“moderate disability in one functional system, or mild disability in three or four 
functional systems, with no impairment to walking,”, while an EDSS score of 7 indicates 
“unable to walk beyond approximately 5m even with aid. Essentially restricted to 
wheelchair; though wheels self in standard wheelchair and transfers alone. Up and about 
in wheelchair some 12 hours a day.” Potential participants were excluded from the study 
if they were non-ambulatory (EDSS score >8), and/or had a history of cardiovascular 
disease or hypertension. All participants were medically approved for exercise prior to 
enrollment, and the Brock University Biosciences Research Ethics Board (REB-14-177-
DITOR) approved this study. Participant characteristics are available in Table 1.  
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3.2 Procedures 
Researchers were fully trained in CPR and First Aid level C, and in the case of 
testing with the RT-200, RT-600 and RT-300, the researchers were Functional Electrical 
Stimulation Course Certified (Restorative Therapies, Baltimore, MA). The testing 
involved an orientation, followed by three phases of testing: the familiarization phase, the 
submaximal exercise testing, and maximal exercise testing. The familiarization phase 
involved six sessions, whereby within each session the participant was familiarized with 
one piece of exercise equipment. These sessions were scheduled with a minimum of 24 
hours between sessions. The submaximal exercise-testing phase involved six testing 
sessions where the participant exercised at a predetermined moderate intensity on one 
piece of exercise equipment each session. These testing sessions were separated by a 
minimum of 48 hours to ensure fatigue from the previous testing session would not affect 
the testing session on the subsequent day.  The third phase involved maximal testing on 
the FES arm leg exercise, and the NuStep exercise machine. These maximal testing 
sessions were separated by a minimum of one week in order to ensure full recovery from 
the previous maximal exercise testing session. All exercise testing was randomized by 
piece of equipment used. Day-to-day differences in MS symptoms were accounted for 
prior to beginning any exercise session.  If the participant reported an exacerbation of any 
symptom common to MS (i.e. increased fatigue, pain, or spasticity) the testing session 
was rescheduled. 
3.2.1 Orientation  
Prior to any data collection, participants were first shown all the exercise 
equipment including Restorative Therapies FES cycle ergometers (FES RT-200, FES RT-
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300A, and FES RT-300L), BWSTT, arm ergometry, and the NuStep. Furthermore, they 
were shown the metabolic cart and the aerobic testing procedures were explained. At this 
time, all questions were answered and the participants were asked to read and sign the 
consent form. Participants were informed of their right to withdraw from the study at 
anytime without penalty.  
3.2.2 Familiarization testing  
Prior to any aerobic testing, all participants completed one familiarization session 
for each of the six pieces of exercise equipment. At this time, the participants were also 
asked which pieces of equipment being used in the study they had previously used. The 
process included an instructional briefing relevant to the equipment, followed by a body 
weight transfer onto the equipment if required. Participants were asked to begin with a 
warm-up by exercising at a low intensity to practice proper technique. The purpose of this 
familiarization session was to determine the settings required to elicit a perceived 
moderate intensity exercise for each participant. These settings were then recorded and 
used for subsequent testing.   
If the exercise involved FES, the stimulation parameters were set at the beginning 
of the exercise session. After the five-minute warm-up, the machine transitioned to a 
ramp-up phase where stimulation intensity (mA) was increased at a rate of 0.5% per 
second until the maximum amplitude was reached. Pulse width and pulse frequency were 
set to 250ms, and 40.0Hz for all participants, unless tetanic contraction could not be 
achieved by only increasing pulse amplitude. In this case, pulse width was reduced, and 
pulse frequency was increased in order to make the sensation of the stimulation more 
comfortable for the participant. During active transition (ramp-up phase), the researcher 
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monitored muscle contractions on the muscles that were stimulated. Ideally, stimulation 
was increased until these muscles reached a tetanic contraction.  
In order to familiarize each participant with the 6-20 Borg Scale, participants were 
asked to incrementally increase the intensity up to 13 points (See appendix B). Ratings of 
perceived exertion were determined peripherally, centrally and overall. To determine 
peripheral RPE participants were asked, “ How hard are your arms and/or legs working?” 
To determine central RPE participants were asked, “How hard are you breathing?” To 
determine overall RPE participants were asked, “How hard are you working overall?” All 
3 questions were asked to the participant in order to try to ensure the overall RPE was as 
close to 13 as possible, without exceeding a moderate intensity. Once the participant 
reached an overall RPE between 11-13 on the overall RPE, the machine settings 
(resistance as well as stimulation parameters when using the FES-exercise equipment) 
were recorded and used for subsequent testing sessions. The sessions ended with a quick 
debriefing and reiteration of testing protocols set to take place in the next phase of 
testing. Any questions the participant had about the testing were also answered during the 
familiarization sessions.  
3.2.3 Aerobic demands of each exercise   
3.2.3.1 General testing procedures 
Each participant performed one moderate intensity exercise test on each piece of 
equipment. In addition, each participant performed a maximal intensity exercise test on 
the RT200 (arm-leg-FES exercise) and the NuStep (voluntary arm-leg exercise). VO2 was 
determined during all moderate and maximal exercise tests. There was at least 24 hours 
of rest between each moderate exercise test and at least one week of rest between 
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maximal exercise tests. Height and weight were collected using a beam weighing scale 
before the first testing day.    
If necessary, the participant was provided assistance to transfer onto the exercise 
machine. The participant was then asked to fasten the gas exchange mask over his or her 
nose and mouth, for the purpose of collecting expired gases. The metabolic analyzer was 
then calibrated while the participant was still at rest in their seat. In the case of FES-
exercise, adhesive electrodes were placed on the quadriceps, hamstring, and gluteal 
muscles for lower limb stimulation.  For stimulation on the upper limbs (during RT-200 
exercise) adhesive electrodes were placed on the biceps, triceps, and posterior deltoid 
muscles. Once the electrodes were applied, the FES parameters were set to the 
comfortable moderate intensity levels pre-determined in the familiarization testing. For 
individualized set-up on the exercise equipment, see section 3.2.4. 
3.2.3.2 Moderate exercise testing 
The exercise session began by fitting the participant with a mask from the 
metabolic cart used to collect gas exchange. The exercise equipment used  during this 
session was then adjusted for each participant (to accommodate leg length, arm length, 
etc.).  The participant began with a five-minute warm-up on the selected piece of exercise 
equipment. Following the five minute warm-up, the exercise machine was set to produce 
the same intensity used during the familiarization period to elicit a moderate RPE. 
Following one minute of exercise at this preset RPE, the participant was asked to rate his 
or her exertion as it pertained their arms and/or legs, breathing and overall exertion based 
on the three questions mentioned previously. Machine settings were then adjusted to 
ensure that the participant was exercising at an RPE score of 11-13 on one or more of the 
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given criteria. The goal of this was for the participant to maintain a self-selected moderate 
intensity on each piece of equipment (corresponding to a 11-13 on the Borg scale) for 10 
minutes. The average VO2 over the final two minutes of exercise was recorded as the 
aerobic demand for that piece of equipment. There was a five-minute cool down phase 
following the exercise test, where participants performed exercise against no resistance, 
and in the case of FES-exercise, with no stimulation (just passive exercise as provided by 
the motor of the machine). After cool down, the participants removed the gas exchange 
mask and were transferred back into their wheelchair (if applicable). Upon completion of 
each session, the participants were asked to fill out the exercise preference questionnaire 
developed by Pelletier and colleagues (2014) for the piece of exercise equipment they 
used that day (Pelletier et al., 2014; see Appendix C).  This questionnaire was intended 
for use by a population with SCI, however it can be analyzed for a sample with MS by 
referring to the MS Canadian society of exercise physiology (CSEP) and MS society of 
Canada exercise guidelines. 
These testing sessions were performed on six different pieces of exercise 
equipment. Thus, the tests were performed on six separate days, separated by at least 24 
hours.  
3.2.3.3 Peak exercise testing 
A VO2 peak test was performed on the NuStep and RT-200 exercise machines. For 
VO2 peak testing, participants warmed up at a very light intensity for five minutes. 
Resistance was then incrementally increased (as described earlier) to elicit a maximal 
exercise until i) volitional fatigue, which was defined by a decrease in speed of 10 units 
for longer than five seconds, or ii) the participant reached an RER of 1.1, or iii) the 
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maximum resistance was achieved. VO2 was measured throughout the test and the VO2 
during the final 30 seconds of the test was recorded as the VO2 peak. Once completing a 
VO2 peak test, the participant did not have another testing session until one week following 
that session.  
3.2.4 Exercise protocol for each piece of equipment  
3.2.4.1Body weight supported treadmill training (BWSTT) 
BWSTT was performed using the Loko S 2000 (Woodway, Germany) under the 
supervision of no less than three volunteers for safety, with at least one being the student 
principal investigator. A harness was fastened along the participant’s waist, and the 
participant was slowly hoisted up to a standing position over the treadmill using cables. 
Once the participant was upright, the mask from the metabolic cart was fitted. The 
appropriate amount of body-weight support was determined in the familiarization session 
so that feet were flat on the treadmill, without buckling at the knees. The amount of body-
weight support remained consistent throughout the testing session.  Once the body weight 
support was set, the treadmill was turned on, and one volunteer on each side of the 
treadmill assisted the leg movement through the gait cycle.  
During submaximal BWSTT, intensity was incrementally increased by increasing the 
speed of the treadmill by 0.5m/s every minute until the overall RPE reached 11-13. VO2 
was collected for the duration of the exercise.  
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3.2.4.2 Arm ergometry  
An Arm ergometer (model 881E, Monark Exercise AB, Poland) was performed 
from a seated position, either in a chair provided or from the participant’s own 
wheelchair.  The participants were fitted with the gas exchange mask prior to beginning 
the exercise. The participants’ hands were secured to the handles with tensor bandages if 
necessary. Participants cycled at 50 revolutions per minute, which was indicated on the 
arm ergometer digital screen.   
During arm ergometry, exercise intensity was incrementally increased by raising 
the resistance by 5 watts per minute (Pelletier et al., 2014). The resistance was adjusted 
on the arm ergometer by tightening a dial on the front of the equipment until the Watts 
measurement moved 5 units higher every minute until the participant scored an overall 
RPE of 11-13.  The cadence was kept constant at 50 revolutions per minute throughout 
the testing. VO2 was measured throughout the duration of the exercise.  
3.2.4.3 NuStep 
The NuStep (model T5, Nustep, Ann Arbor, MI) exercise included a participant 
transfer onto an adjustable seat, securing the feet with straps, and adjusting specific 
settings to the participant based on height and arm length. The participant was asked to 
maintain the speed identified as a moderate intensity during the familiarization session.    
During NuStep recumbent stepping exercise, intensity was incrementally 
increased by raising the resistance of the machine by 1 unit per minute (the machine has 
built-in resistance levels ranging from 0-15). The cadence was kept constant at 100 steps 
per minute throughout the testing. For submaximal testing, the intensity (resistance) was 
increased every minute until the participant scored a RPE of 11-13. At this point, VO2 
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was recorded. For maximal testing, the intensity was increased by one unit every minute 
until one of the following criteria was reached: i) RER reached 1.13, ii) the participant 
gave up from exhaustion, or iii) the participant could no longer maintain a speed of 100 
steps per minute. At this point maximal VO2 was recorded as VO2 peak for this exercise.  
3.2.4.4 RT300, FES-L and FES-A exercise  
 Electrodes were applied to the quadriceps, hamstrings, and gluteal muscles 
during FES leg cycling (FES-L), or to the biceps, triceps, and posterior deltoid during 
FES arm cycling (FES-A).  The participant then had their wheelchair fastened to the 
exercise machine, or were asked to sit in a chair and place their feet on the pedals, and the 
gas exchange mask was fitted to the participant.  
During RT300 exercise, intensity was incrementally increased by raising the 
resistance of the machine by one Nm per minute. The cadence and stimulation parameters 
(amplitude, pulse width and frequency) were kept constant throughout the testing, as 
determined during the familiarization session. The cadence was kept constant at 50 
revolutions per minute throughout the testing.  
 
3.2.4.5 RT200, FES-LA exercise  
Electrodes were applied to the quadriceps, hamstrings, gluteal, biceps, triceps, and 
posterior deltoid muscles. The participant then transferred on the exercise seat if required, 
and feet and arms were fastened to the pedals if necessary, and the gas exchange mask 
was fitted to the participant. Then, the RT-200 was turned on and set to the speed 
determined in the familiarization session.  
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During RT200 submaximal exercise, intensity was incrementally increased by 
raising the resistance of the machine by one Nm per minute. The stimulation parameters 
(amplitude, pulse width and frequency) were kept constant throughout the testing as 
determined during the familiarization session. The cadence was kept constant at 50 
revolutions per minute throughout the testing. For maximal testing, the intensity was 
incrementally increased by 1.0 Nm every minute until one of the following criteria was 
reached: i) RER reached 1.13, ii) the participant gave up from exhaustion, or iii) the 
participant could no longer maintain a speed of 50 revolutions per minute. At this point 
maximal VO2 was recorded as VO2 peak for this exercise. 
3.3 Outcome measures  
 
3.3.1 Steady- state submaximal VO2  
 VO2 relative to body mass was recorded using a VacuMed Vista Mini CPX made 
by VacuMed (Ventura, California) metabolic analyzer. This analyzer collected a sample 
of air from a mask the participant wore during exercise testing. This air sample was 
analyzed by the Vista Mini CPX, and VO2 data was collected.  A plateau in oxygen 
consumption during moderate exercise testing identified submaximal VO2. The mean of 
the last five data points of the relative VO2 was calculated. One data point during VO2 
collected was the average VO2 collected over a 20 second time period. Therefore, the 
submaximal VO2 was an average VO2 calculated from 120 seconds of exercise. This 
number was recorded as the submaximal VO2 for the participant on that specific exercise. 
 
3.3.2 VO2 peak  
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 VO2 peak relative to body mass was recorded using the metabolic analyzer. This 
outcome measure was used for the NuStep and RT200 machines during the maximal 
exercise testing sessions. VO2 peak was defined as the maximum oxygen consumption 
relative to body weight achieved during the maximal exercise test. VO2 peak was 
recorded as the maximal point on the graph achieved during the test. Each point of data 
represented an average VO2 taken over a 20 second time period.  
 
3.3.3 RPE 
 The Borg 6-20 scale was used to identify moderate exercise intensity. Moderate 
exercise intensity was defined as a 13 on the scale. Once the participant reached an 
overall RPE of 11-13 during an intensity measure, this value was recorded. 
 
3.3.4 Exercise preference  
The exercise preference questionnaire used in this study was developed for SCI 
by Pelletier and colleagues (2014) (Appendix C). This questionnaire can be used with no 
changes for a sample with MS, however in analysis the MS exercise guidelines will be 
discussed instead of the SCI exercise guidelines. This questionnaire was separated into 
four components:  pain, safety, enjoyment, and adherence to exercise guidelines. Three 
questions were asked about pain on this questionnaire. The participants rated pain on a 
scale of 1 to 7, where 7 was extreme pain and 1was no pain at all. These scores were 
summed and a higher score indicated more pain. Two questions were asked about safety. 
The participants rated safety on a scale of 1 to7, where 7 indicated competency and 
feelings of safety and 1indicated no competency or feelings of safety using the equipment 
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independently. The scores on these questions were summed, and a higher score indicated 
higher feelings of safety while using the equipment. Enjoyment was rated on a scale of 1 
to 7, where 7 indicated full enjoyment and1 indicated no enjoyment. Two questions were 
asked regarding adherence to MS exercise guidelines. The participants indicated how 
frequently they could expect using the exercise equipment per week, and this number was 
compared to the current exercise guidelines for MS, and this was similarly done for 
exercise duration. 
3.4 Statistical Analysis  
Statistical analysis was performed using Microsoft Office Excel 2010, and SPSS 
version 20. Significant p-values were determined at p<.05. The confidence interval used 
was 95%.  
3.4.1 Steady-state submaximal VO2  
The mean value of the last 5-data points collected during this exercise test was 
used in analysis. Each data point represents a mean value of oxygen consumption during 
20 seconds of exercise. Variability was represented using standard deviation. A one-way, 
repeated measures ANOVA was used to analyze these means from each piece of exercise 
equipment, with a confidence interval of 95%. Following a significant p-value, a 
Bonferroni correction post-hoc test was used to compare means. 
3.4.2 VO2 peak 
The maximum oxygen consumption data point collected during the exercise tests 
was used as the VO2 peak value in analysis. This data point is representative of a mean 
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oxygen consumption value from 20 seconds of exercise. A dependent samples t-test was 
used to determine significance using a p-value.  
3.4.3 FES vs. Non-FES 
 The mean oxygen consumption values collected during the submaximal VO2 
testing are used in this analysis. The traditional non-FES equipment used in this study 
was matched for the FES version of the similar or identical exercise equipment. 
Variability was represented using standard deviation. A dependent samples t-test was 
performed on the means from the above submaximal test to determine the p-value. This 
test was performed on three comparisons: the FES-A and arm ergometer, the FES-L and 
the BWSTT, and the RT200 and the NuStep.  
 
3.4.3 Exercise preference  
The questionnaire was divided in to five sections prior to analysis: pain, safety, 
enjoyment, exercise frequency, and exercise duration. For pain, safety, and enjoyment, 
the questionnaire was scored for each piece of equipment, and the mean value was used 
in analysis. Variability was represented using the standard deviation. A one-way, 
repeated measures ANOVA was performed on the means of these sections in order to 
determine significance using the p-value. If a significant p-value was found, then 
pairwise comparisons were performed using a Bonferroni post-hoc test. For exercise 
frequency and duration, the questionnaires were scored, and the average value was used 
in analysis. The average scores determined from these sections were then compared to the 
CSEP and MS society exercise guideline to determine whether participants would use 
these selected pieces of equipment in adherence to the current guidelines.  
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Chapter 4: Results  
4.1 Exercise testing adherence 
 
Twelve participants were recruited for this study. Two participants were dropped 
from the study due to attendance issues, and one participant was excluded from VO2 peak 
testing due to the inability to complete the maximal testing session subsequent to health 
problems related to changes in pharmacological treatment, however this participant was 
included in all other analyses. Therefore, a total of ten participants met the study 
requirements and comprise the final data. 
 
4.2 Submaximal testing measures  
 
One-way, repeated measures ANOVA determined that there was a significant 
main effect in mean submaximal VO2 (ml•kg•min-1) between the six selected pieces of 
exercise equipment (F (5,45)= 8.8, p = 0.00). Variances of the differences between all 
possible pairs of groups were equal, and the assumption of sphericity was upheld 
(χ2(14)=0.5, η2 = 0.5, p >0.005, see Figure 1). A Bonferroni post-hoc test was performed, 
and revealed three significant differences between equipment. The arm ergometer was 
significantly less aerobically demanding than the NuStep, BWSTT and FES-LA (9.54 ± 
0.7 ml•kg•min-1 compared to 14.6 ± 1.3 ml•kg•min-1, p = .01; 13.4 ± 0.7 ml•kg•min-1, p = 
.031; 13.8 ± 1.2 ml•kg•min-1, p = .03 respectively; see Table 2).  
There was no analysis performed on the central and peripheral scores, as data was 
inconsistently reported with the participants due to challenges answering the questions 
and continuing with the exercise. Therefore, it was decided to leave these RPE scores out 
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of data analysis.  A one-way ANOVA determined a significant main effect between the 
overall RPE of exercise equipment (p = 0.014), however a Bonferroni post-hoc test 
revealed no significant differences. Therefore, RPE was consistent between exercise 
modalities (Table 4). 
4.3 VO2 peak testing measures 
 
Not every participant reached the requirements of a VO2 max test, even with the 
secondary criteria. Only 1 participant out of the 9 included in analysis reached an RER of 
1.1. Therefore, this test was measured as a VO2 peak, not a VO2 max test.  
A dependent samples t-test was performed to determine whether the NuStep or 
RT 200 exercise was more aerobically demanding when tested at a maximal capacity. No 
significant difference was found between these two pieces of equipment (19.2 ± 1.0 
ml•kg•min-1 vs. 18.0 ± 1.1 ml•kg•min-1, p= 0.97), respectively.   A sub-analysis was 
performed on the participants with an EDSS of 6.0 or higher. A dependent samples t-test 
on this sample (n=5) showed a trend for a significant difference (NuStep; 17.5 
ml•kg•min-1  ± 2.5 vs. FES-LA; 16.8± 2.3 ml•kg•min-1, p = 0.07), however no significant 
difference was found between the NuStep and the RT-200 exercise.  
4.4 Comparing non-FES to FES exercise  
 
Exercise equipment used in this study was paired based on exercise movement. 
The arm ergometer was compared to the functional electrical stimulation arm exercise 
(FES-A), the NuStep was compared to the FES-LA, and the BWSTT was compared to 
the functional electrical stimulation leg exercise (FES-L). A dependent samples t-test was 
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performed on each of these pairs. No significant differences were found between the arm 
ergometer and FES-A exercise (p=0.8). No significant difference was found between the 
NuStep and FES-AL (p=0.2), as well as the BWSTT and FES-L (p=0.2; Table 2).  
4.5 Measures of exercise preference  
 
  i) Pain: A one-way, repeated measures ANOVA was performed on the pain 
scores of the six pieces of exercise equipment used in this study. No statistically 
significant difference was found (p=0.9, η2= 0.3, Table 3).   
ii) Safety: A one-way, repeated measures ANOVA was performed on the safety 
scores of the six pieces of exercise equipment used in this study. A significant main effect 
for equipment was found (p = 0.00, η2=0.4), however the Bonferroni post-hoc testing 
showed no significant differences in safety between any of the pieces of equipment 
(Table 3).  
iii) Enjoyment: A one-way, repeated measures ANOVA was performed on 
enjoyment of the six pieces of exercise equipment used in this study. No significant main 
effect for equipment was found for enjoyment (p=0.5, η2= 0.2, Table 3).  
iv) Exercise Frequency: A one-way, repeated measures ANOVA was performed 
on the exercise frequency on all six pieces of exercise equipment. No significant main 
effect for equipment was found for exercise frequency (p=0.95, η2=0.2, Table 3). The 
current exercise guidelines for individuals with MS (Latimer- Cheung et al., 2013) 
suggest the minimum required exercise frequency is two times per week. The participants 
felt they could use the exercise equipment in adherence with MS exercise frequency 
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guidelines Table 3).  
v) Exercise Duration: A one-way repeated measures ANOVA was performed on 
the exercise duration on all six pieces of exercise equipment. No significant main effect 
was found for exercise duration (p=0.3, η2=0.1, Table 3). The current exercise guidelines 
for individuals with MS (Latimer-Cheung et al., 2013) suggest a minimum required 
duration of 30 minutes per session. However none of the participants in the study felt 
they could use the equipment for the duration suggested by the MS exercise guidelines 
(Table 3).    
Chapter 5: Discussion 
 
The main finding from this study was that combined arm and leg exercises 
(BWSTT, FES-LA, and NuStep) were more aerobically demanding than the arm-only 
exercise (arm ergometry) when performed at moderate intensity exercise.  This was 
evidenced by a significantly higher submaximal VO2 during NuStep, FES-LA and 
BWSTT exercise compared to the submaximal VO2 during arm ergometry. Further, 
exercises using FES added no additional aerobic benefit compared to non-FES exercise 
modalities in the three submaximal intensity comparisons. In addition, there was no 
preference of exercise modality by the participants, which was evidenced by no 
significant differences in pain scores (p= 0.9), safety scores (p > 0.05) or enjoyment on 
the exercise preference questionnaire (p = 0.5). All equipment met MS exercise 
guidelines for frequency, indicating that participants would adhere to the exercise 
frequency guidelines for MS on each piece of equipment. However, none of the exercise 
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equipment used in this study met exercise duration guidelines, indicating that the 
participants did not find any of the exercises sustainable for a 30-minute duration.  
 
5.1 Comparisons of aerobic demand during moderate exercise  
 
This was the first study to compare the submaximal aerobic energy cost of various 
exercise modalities in individuals with MS. There are no other submaximal values 
available to directly compare the current results to. However, it is important to examine 
submaximal intensities, as this is realistically what individuals with MS will be doing in 
accordance to MS exercise guidelines. Furthermore, current research regarding exercise 
interventions available for this population is limited (Latimer-Cheung et al., 2013), which 
makes it difficult to compare the submaximal aerobic demand of the exercise equipment 
found in this study to values in the current literature.  
 It is promising that there were no statistical differences in submaximal aerobic 
demand between the exercise modalities tested, with the exception of arm ergometry. 
This suggests that all exercise modalities used in this study, with the exception of arm 
ergometry, are similar to each other in their ability to elicit an aerobic stimulus when used 
at a submaximal intensity. The current results are comparable to a study by Pelletier and 
colleagues (2014), where submaximal aerobic demand was tested on various types of 
accessible exercise equipment in individuals with spinal cord injury. The equipment 
tested included an arm ergometer, arm glider, arm-leg recumbent stepper, and arm-leg 
cycle ergometer, and no differences were found in submaximal aerobic demand when 
exercising at a moderate to vigorous intensity, as indicated by RPE.  However, our results 
differed to the Pelletier and colleagues study (2014), as they did not find any aerobic 
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differences between arm ergometry and the NuStep arm-leg recumbent exercise. One 
explanation for this may be that in the study by Pelletier et al. (2014), the overall RPE 
scores were more variable than in the current study. In the study by Pelletier and 
colleagues (2014), participants were asked to exercise between 3-6 on the ten point 
Borg’s scale, which corresponds to a range of “moderate” to “very hard” intensity. In the 
present study, intensity was sustained once the participant exercised between 11-13 on 
the 6-20 Borg’s scale. This corresponds to “light” to “somewhat hard” intensity. 
Therefore, this study may have controlled variations in RPE more restrictively as the 
mean RPE was 12 points for every piece of equipment, indicating a very consistent 
perceived intensity between all pieces of exercise equipment tested (table 4). The tight 
control of variability may explain why a significant difference was detected in this study 
compared to the Pelletier and colleagues (2014) study. Furthermore, anecdotal comments 
from our participants support that in a sample with MS, arm ergometry may be more 
fatiguing than the NuStep exercise. Following the arm ergometer exercise session, 
participants commonly reported that they felt “more tired” and “drained” following the 
arm ergometer session than the other exercises they had completed testing. However, 
fatigue was not measured in this study to determine whether the effects of fatigue on the 
arm ergometer were related to lower VO2 at submaximal intensities. Therefore, 
considering Pelletier and colleagues (2014) used a sample with SCI, the effects of fatigue 
may be another key difference between distinguishing the two studies.  
The arm ergometer and the FES-A used in this study focus on the smallest major 
muscle groups to produce a moderate intensity aerobic exercise compared to the other 
four pieces of equipment. However, the arm ergometer produced less of an aerobic 
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stimulus than the BWSTT and the arm-leg recumbent stepper, whereas the FES-A was 
found to be equivalent to BWSTT and the arm-leg recumbent stepper (figure 2). In a 
study by Mostert and Kesselring (2002), excessive fatigue (as indicated by the fatigue 
severity scale) during bicycle aerobic exercise was found to be 67% greater in a group 
with MS compared to a control group of healthy individuals. Furthermore, a study by 
Haan and colleagues (2000) examined the contractile properties of muscle in individuals 
with MS by using FES. They found that larger reductions in muscle performance 
occurred during voluntary exercise due to greater central fatigue, while FES allowed for 
exercise to occur at a higher resistance for a longer period of time. The findings from 
Haan and colleagues (2000) are in line with the results of the current study, as the 
addition of FES in the FES-A exercise may have prevented excessive central fatigue 
during steady-state exercise. In this instance, the addition of FES to arm cycling may 
have benefited steady state exercise by preventing central fatigue, as using FES allows 
for an involuntary muscle contraction bypassing the central nervous system. Likewise, 
during arm ergometry, maintaining moderate intensity exercise until steady state is 
achieved may have caused too much central fatigue. This could explain why moderate 
exertion on the arm ergometer was not as aerobically demanding as moderate exertion on 
the FES-A when comparing them to the BWSTT and the arm-leg recumbent stepper.  
Central and peripheral fatigue was not measured in the current study, so future research 
will be required to address this theory.  
5.2 Comparisons of aerobic demand during maximal exercise  
VO2 peak was measured on the arm-leg recumbent exercise, and the FES-LA 
exercise equipment, which were hypothesized to elicit the highest aerobic demand during 
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maximal intensity exercise. In the present study, the mean VO2 peaks achieved on the 
arm-leg recumbent exercise and the FES-LA were 19.2 ± 1.0 ml•kg•min-1, and 18.0 ± 1.1 
ml•kg•min-1, respectively. These values are comparable to VO2 peak values achieved in a 
study performed by Morrison and colleagues (2008), where VO2 peak testing was done to 
test the reliability of RPE in individuals with MS. In their study, participants exercised 
using a leg ergometer. The mean VO2 peak value achieved by individuals with MS was 
22.9 ± 6.2 ml•kg•min-1. The slightly higher VO2 peak values achieved in their study were 
most likely a result of a participant group that was lower on the EDSS scale. Individuals 
were excluded if their EDSS score was higher than 3, where the EDSS scores in the 
current study ranged from 4 to 6.5, and it is well accepted that aerobic capacity decreases 
with increasing MS severity, as indicated by this scale (Langeskov-Christensen et al., 
2014). Therefore, the arm-leg recumbent exercise and the FES-LA equipment may be 
effective to perform VO2 peak testing in individuals with MS that have a higher disability 
score, as indicated by the EDSS.  
The VO2 peak values on the arm-leg recumbent stepper and FES-LA were not 
statistically significantly different, indicating that both pieces of equipment were equal at 
eliciting a peak aerobic response. This result differed from the proposed hypothesis, as it 
was expected that the addition of FES to the exercise would induce a greater aerobic 
response than the non-FES alternative. One possible explanation for this is that our 
participant sample was too low on the EDSS scale (mean EDSS score of 5.4) to detect 
peak aerobic benefits of FES exercise. This EDSS score indicates that the average 
participant is ambulatory without an aid for at least 200 meters. Therefore, these 
participants may not have muscles that are partially paralyzed to an extent where the 
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addition of FES would supplement their aerobic exercise and allow them to reach a 
higher peak stimulus. Future large-scale studies should separate samples by EDSS 
severity in order to detect if the FES is beneficial at higher EDSS scores.  
 
5.3 FES and aerobic exercise 
 
In the current study, the addition of FES to an exercise did not significantly affect 
aerobic demand in both submaximal and peak tests. There are currently no other studies 
that have compared how the addition of FES affects the aerobic demand of traditional 
modalities at either submaximal or maximal workloads in individuals with MS. However, 
a study by Deley and colleagues (2008) compared the effects of FES exercise to 
traditional exercise on aerobic fitness measures in individuals with chronic heart failure. 
Participants were allocated to either a FES group or conventional exercise-training group. 
Both exercise groups participates in a one-hour exercise session five days a week for five 
weeks. The conventional training group and the electrical stimulation groups used 
traditional aerobic exercises during the exercise sessions, such as treadmill and bicycle 
training. The FES group had low-frequency stimulation applied to their quadriceps and 
soleus muscles, which trained the muscles in intervals of 12s on and 8s off. VO2 peak 
was measured before and after the exercise intervention. Both groups had significant 
improvements in VO2 peak, however there was no additional aerobic benefit to using the 
FES exercise equipment compared to the conventional equipment, which is consistent 
with the findings of our study. Our findings support that both traditional and FES 
equipment are ideal forms of aerobic exercise in the MS population, as the aerobic 
benefits are similar using both modalities.  
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Our findings do not support our initial hypothesis that the addition of FES would 
require higher aerobic demand at any given exercise intensity. It is possible that 
electrically stimulated muscle contractions provide the same aerobic demand as a 
traditional muscle contraction regardless of muscle paralysis. In this instance, FES 
exercise would be aerobically beneficial to the same extent as non- FES exercise.  
 
5.4 Limiting factors of FES  
 
Sensation may be a limiting factor for providing optimal electrical stimulation for 
exercise. In an ideal FES exercise set-up, the electrodes are set to stimulate tetanic 
contractions of the muscles. However, this was not always possible in our study as some 
of the participants experienced discomfort from the stimulation before a tetanic 
contraction was produced. Therefore, muscle stimulation was below optimal for each 
exercise session.  
Furthermore, for the VO2 peak tests, participants with a lower EDSS score may 
not have achieved a true VO2 peak, as the maximum resistance and speed on the 
equipment may have been reached before the participant was at their maximal exercise 
intensity. On another note, maximal exercise intensity on the FES equipment in this study 
was limited as the highest speed attainable was 50 rpm, and surpassing this speed results 
in decalibration of the stimulation from the exercise movement. Likewise, the maximum 
possible resistance was 15.0 Nm at any given speed on the equipment. As a result, seven 
participants in this study did not attain a maximal exercise capacity. In fact, once the 
limits of these machines were reached, equipment related issues arose (such as the pedals 
on the FES-LA machine desynchronizing from the exercise program). Hence, further 
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development of this equipment should focus on providing higher exercise intensities, so 
individuals with less severe MS can still utilize these machines for optimal aerobic 
exercise benefits, especially when the equipment is being used at VO2 peak exercise 
intensity.   
 
5.5 Applicability to exercise guidelines  
All exercises in this study were similar in regards to pain experienced, perceived 
safety using the equipment and level of enjoyment. Therefore, the arm-leg recumbent 
stepper, FES-leg cycle, FES-arm cycle, FES arm-leg recumbent stepper, and BWSTT are 
all considered appropriate exercise modalities to include in an aerobic exercise program 
for people with MS.  
 
All equipment used in this study, with the exception of the arm ergometer were 
similar in their ability to elicit an aerobic stimulus. Practically and realistically however, 
not all equipment tested is suitable for home or unsupervised use. The arm ergometer was 
an inferior aerobic exercise when compared to the other five machines, but is safe to be 
used at home or in a therapy setting. An arm ergometer requires little to no supervision 
and individuals with severe disability can set themselves up independently, making it an 
important piece of exercise equipment regardless of its inability to induce similar 
cardiovascular response as the other equipment.  
The BWSTT can only be used with full supervision during setup, the entirety of 
the exercise session, and after session completion. This machine requires a minimum of 
two assistants at all times. Although the BWSTT was comparable to the other equipment, 
it is important to note that it may not be the most feasible modality considering the 
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aerobic benefits are similar to other more self-reliant exercise equipment, such as the 
arm-leg recumbent stepper (NuStep). The arm-leg recumbent stepper (NuStep) may be of 
particular utility for individuals with mild to moderate disability, as it can be 
independently used, or easily and quickly set up by an assistant, and elicits the same 
aerobic benefits as the other equipment tested in this study.  
In regards to the FES exercise modalities, the equipment can be used 
independently once the individual has been trained on the device. Further, using FES may 
be appropriate for individuals with moderate to severe MS, as there are additional 
benefits of an aerobic exercise using muscle stimulation in muscles that are fully or 
partially paralyzed such as: increasing blood flow to these muscles, increasing muscle 
mass and reducing spasticity (Peckham and Knutson, 2005).  
 
5.6 Limitations and future directions 
 
The primary limitation of the current study was its small sample size. Considering 
the inclusion criteria for this study was very narrow and specific, the pool of individuals 
with MS that were eligible for this study was small and limited to one geographic region, 
as participants had to be available multiple times for testing. However, given the 
scientific necessity of such a narrow inclusion criteria, we feel that the study still has 
importance in this small but important subgroup of MS patients.  
Another limitation is the fact that the findings from this study are only applicable 
to individuals with MS who are currently ambulatory or semi-ambulatory, with an EDSS 
score of less than 8. This may be perceived as a limitation, however the current CSEP and 
MS society exercise guidelines in fact focus on this same group of individuals suffering 
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from MS. Furthermore, the traditional exercise modalities used in this study require some 
volitional effort in order to exercise. Therefore, these exercises may not be ideal for 
individuals with a higher EDSS score. Future research should examine whether the FES 
exercise equipment used in this study can elicit an aerobic response in individuals with 
MS who are non-ambulatory (EDSS>8). By doing so, this acquired knowledge will help 
to expand the current MS exercise guidelines to a more severely disabled population.  
 
 
As for future studies, they should also include perceptions of fatigue on various 
modalities of exercise equipment during a sustained aerobic exercise, and its relation 
perceived intensity using the RPE scale. Furthermore, comparing the effects of fatigue in 
FES exercises compared to the traditional modalities during moderate intensity exercise 
in different EDSS scale groups may be key in identifying when FES exercises are best 
used in an exercise prescription for MS. Answering these questions in an MS population 
may lead to maximizing the utility and efficacy of aerobic exercise, inform and advance 
the MS exercise guidelines in a consumer-centered manner, and improve the 
sustainability of exercise programs over time.   
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Figures and Tables  
 
 
 
Table 1. Participant characteristics  
# Age 
(years) 
Sex  Type of 
MS 
Years-post 
Diagnosis 
EDSS Height 
(cm) 
Body Mass 
(kg) 
1 58 F SPMS 36 6 156 59 
2 36 M RRMS 5 5 189 94 
3 46 F RRMS 2 5 167 89 
4 56 M SPMS 22 6.5 166 59 
5 49 F SPMS 38 6 160 58 
6 61 F RRMS 16 6 175 105 
7 43 F RRMS 9 6 169 112 
8 41 F RRMS 8 4 165 65 
9 58 F SPMS 24 6.5 169 108 
10 61 F PPMS 4 4 160 74 
Abbreviations: MS, multiple sclerosis, EDSS, expanded disability status scale, SPMS, secondary progressive multiple 
sclerosis, RRMS, relapsing remitting multiple sclerosis, PPMS, primary progressive multiple sclerosis, F, female, M, 
male 
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Figure 1. A comparison of the submaximal aerobic demands of each piece of exercise  
equipment. 
 
 
Abbreviations: VO2, volume of oxygen, FESLA, functional electrical stimulation arm leg exercise, FESL functional 
electrical stimulation leg exercise, BWSTT, body weight support treadmill training, FESA, functional electrical 
stimulation arm exercise, ACE, arm crank ergometry  
Values are the mean± s.d. 
* Denotes a significantly lower VO2 value for ACE compared to each of: FES-LA, NuStep, BWSTT.   
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Table 2. Comparisons between the FES vs. non-FES equipment for submaximal aerobic 
demand. 
  
 Exercise 
equipment  
 VO2 (ml·kg-1·min-1) p-value % VO2 
peak 
p-value d 
 Arm-ergometer 9.54 ± 0.7 0.77 47.7 ±11.0 0.72 0.12 
 FES-A 9.14 ± 1.2  45.0 ±21.1 
      
 NuStep 14.57 ± 1.3 0.23 71.8 ± 15.7 0.36 0.19 
 FES-LA 13.79 ± 1.2  68.4 ±15.1 
      
 BWSTT 13.36 ± 0.7 0.24 67.2 ±12.4 0.21 0.36 
 FES-L 12.31 ± 1.1  61.5 ±17.0 
Abbreviations: VO2, volume of oxygen, FES-A, functional electrical stimulation arm exercise, FES-LA, functional 
electrical stimulation arm leg exercise, BWSTT, body weight supported treadmill training, FES-L, functional electrical 
stimulation leg exercise. d, cohen’s d effect size.  
Values are mean ± s.d.  
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Table 3.  One-way repeated measures ANOVA comparing preference of each piece of 
exercise equipment.  
 
 AE FES-A NuStep  FES-LA BWSTT FES-L 
Sample Size 10 10 10 10 10 10 
Used Previously 3 0 4 1 2 2 
Pain 6.8 ± 3.8 6.9 ± 3.4 6.0 ± 3.1 5.9 ± 3.5 6.5 ± 3.3 6.3 ± 3.0 
Enjoyment 4.1 ± 2.1 5.1 ± 1.5 6.2 ± 1.2 5.8 ± 1.2 5.3 ± 2.0 4.7 ± 1.7 
Safety 12.6 ± 1.9 11.3 ± 3.5 12.8 ± 1.8 9.8 ± 3.9 7.8 ± 4.6 9.1 ± 3.6 
Minutes  14.5 ± 7.2 16.0 ± 6.1 18.5 ± 5.8 19.0 ± 8.1 14.6 ± 6.6  16.0 ± 7.4 
Times/week 2.5 ± 1.3 2.7 ± 0.8 3.6 ± 1.3 2.8 ± 0.9 2.3 ± 1.3 2.5 ± 0.8  
Abbreviations: AE, arm ergometer, FES-A, functional electrical stimulation arm exercise, FES-LA, functional 
electrical stimulation arm leg exercise, BWSTT, body weight supported treadmill training, FES-L, functional electrical 
stimulation leg exercise.  
Values for pain, enjoyment, safety, minutes and times/week are means ±  s.d.   
Values for Used Previously are the number of participants in the sample that have experience with the piece of 
equipment.  
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Table 4. Mean RPE scores on each piece of exercise equipment during submaximal 
exercise.  
 
 Mean RPE Median RPE 
Arm ergometer 12.7±0.7 13 
FES-A 11.4±1.3 11 
Nustep 12.3±1.0 12.5 
FES-LA 12.1±1.4 13 
BWSTT 12.5±0.7 13 
FES-L 12.5±0.7 13 
Abbreviations: RPE, rate of perceived exertion, FES-A, functional electrical stimulation arm exercise, FES-LA, 
functional electrical stimulation arm leg exercise, BWSTT, body weight supported treadmill training, FES-L, functional 
electrical stimulation leg exercise.  
Values are means ± s.d. 
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Appendix A 
EDSS Scale (Kurtzke, 1983) 
 
0= Normal neurologic exam (all grade 0 in functional systems [FS]; cerebral grade 1 
acceptable)  
 
1.0= No disability, minimal signs in one FS (ie. grade 1 excluding cerebral grade 1) 
 
1.5= No disability minimal signs in more than one FS (more than one grade 1 excluding 
cerebral grade 1)  
 
2.0= Minimal disability in one FS (one FS grade 2, others 0 or 1)  
 
2.5= Minimal disability in two FS (two FS grade 2, others 0 or 1)  
 
3.0 Moderate disability in one FS (one FS grade 3, others 0 or 1), or mild disability in 
three or four FS (three/four FS grade 2, others 0 or 1) though fully ambulatory.  
 
3.5= Fully ambulatory but with moderate disability in one FS (one grade 3) and in one or 
two FS grade 2; or two FS grade 3/ or five FS grade 2 (others 0 or 1).  
 
4.0= Fully ambulatory without aid, self-sufficient, and about some 12 hours a day despite 
relatively severe disability consisting of one FS grade 4 (others 0 or 1), or combinations 
of lesser grades exceeding limits of previous steps. Able to walk without air or rest some 
500 meters. 
 
4.5= Fully ambulatory without aid, up and about much of the day, able to work a full day, 
may otherwise have some limitation of full activity or require minimal assistance; 
characterized by relatively severe disability, usually consisting of one FS grade 4 (others 
0 or 1) or combinations of lesser grades exceeding limits of previous steps. Able to walk 
without aid or rest for some 300 meters.  
 
5.0= Ambulatory without aid or rest for about 200 meters; disability severe enough to 
impair full daily activities (eg. to work full day without special provisions). (Usual FS 
equivalents are one grade 5 alone, others 0 or 1; or combinations of lesser grades usually 
exceeding specifications for step 4.0)  
 
5.5= Ambulatory without air or rest for about 100 meters; disability severe enough to 
preclude full daily activities (Usual FS equivalents are one grade 5 alone, others 0 or 1; or 
combination or lesser grades usually exceeding those for step 4.0).  
 
6.0= Intermittent or unilateral constant assistance (cane, crutch, or brace) required to walk 
about 100 meters with or without resting. (Usual FS equivalents are combinations with 
more than two FS grades 3+). 
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6.5= Constant assistance (canes, crutches, or braces) required to walk about 20 meters 
without resting. (Usual FS equivalents are combinations with more than two FS grades 
3+). 
  
7.0= Unable to walk beyond about 5 meters even with aid, essentially restricted to 
wheelchair; wheels self in standard wheelchair and transfers alone; up and about in 
wheelchair some 12 hours a day.  
 
7.5= Unable to take more than a few steps; restricted to wheelchair; may need air in 
transfer; wheels self but cannot carry on in standard wheelchair a full day; may require 
motorized wheelchair.  
 
8.0= Essentially restricted to bed or chair or perambulated in wheelchair, but may be out 
of bed itself much of the day; retains many self-care functions; generally has effective use 
of arms.  
 
8.5= Essentially restricted to bed much of the day’ has some effective use of arm (s); 
retains some self-care functions. 
  
9.0= Helpless bed patient; can communicate and eat.  
 
9.5= Totally helpless bed patient; unable to communicate effectively or eat/swallow. 
 
10= Death due to MS.   
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Appendix B 
Borg’s Scale of Rating of Perceived Exertion 
 
6 No exertion at all  
7 Extremely light  
8  Extremely light 
9 Very light  
10  
11 Light 
12  
13 Somewhat hard  
14 
15 Hard (heavy) 
16  
17 Very hard 
18  
19 Extremely hard  
20 Maximal exertion  
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Appendix C 
Equipment Preference Questionnaire 
(Pelletier C., Latimer-Cheung A. & Hicks A., 2014) 
 
 
Pain  
1. How much shoulder pain did you feel? 
No pain 1 2 3 4 5 6 7  Extreme Pain 
2. How much bodily pain & physical discomfort do you typically experience? 
No pain 1 2 3 4 5 6 7 Extreme Pain 
3. How much bodily pain & physical discomfort did you feel using this specific piece of 
equipment? 
No pain 1 2 3 4 5 6 7 Extreme pain  
 
 
Safety -  
1. How confident are you in your ability to use each piece of exercise equipment? 
a) Without assistance?  
No confident  1 2 3 4 5 6 7 Fully capable 
b) Safely without causing injury? 
No confident  1 2 3 4 5 6 7 Fully capable 
 
 
Enjoyment-   
1. How much did you like using this specific piece of exercise equipment? 
Do not like it 1 2 3 4 5 6 7 Liked a lot  
 
(SCI) Exercise Guidelines 
1.  Assuming you are very motivated & fit, how many times per week could you imagine 
yourself using this piece of equipment? 
a) 1 b) 2 c) 3 d) 4 e)>4 
2. How many minutes could you imagine yourself using this specific piece of exercise 
equipment? 
a)<5min b)5min c)10min d)15min e)20min f)25min
 g)30min h)other______ 
 
 
 
 
 
